Protagenic Therapeutics, Inc.new (PTIX) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Aug 24, 2026.
- Filings shown
- 7
- Open-market buys
- 7
- Open-market sells
- 0
- Buys, 10b5-1 box not checked
- 7 of 7
Counts cover the 7 most recent Form 4 filings Tradune holds for PTIX (filed Aug 3 – Aug 24, 2026). SEC EDGAR Form 4 filings for PTIX last checked Nov 21, 2026, 09:00 UTC; the latest PTIX filing Tradune holds was filed Aug 24, 2026. This is not guaranteed to be the complete record — see PTIX's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 1 filing Tradune holds for PTIX filed Aug 24, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold |
|---|---|---|---|---|
| Garo H. ArmenEXEC. CHAIR & PRINCIPAL OFF | 1 | 0 | 20,000 | — |
Dollar value: value undisclosed — at least one Form 4 in this window has no complete disclosed value, so totals are not shown.
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at PTIX
Insiders reported 7 open-market purchases of PTIX between Aug 3, 2026 and Aug 24, 2026, across 1 distinct buyer. The most recent purchase was reported by Garo H. Armen (EXEC. CHAIR & PRINCIPAL OFF) on Aug 21, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 20,000 | $0.65 | 73,533 | +37% | Aug 21, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 16,634 | $0.59 | 53,533 | +45% | Aug 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,700 | $0.35 | 36,899 | +7.9% | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,220 | $0.32 | 34,199 | +6.9% | Aug 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 685 | $0.22 | 31,979 | +2.2% | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 5,000 | $0.26 | 31,294 | +19% | Aug 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 26,291 | $0.18 | 26,291 | — | Jul 30, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to PTIX's (Aug 24, 2026).
Frequently asked about PTIX insider activity
How many insiders bought PTIX stock in these Form 4 filings?
1 distinct insider at Protagenic Therapeutics, Inc.new reported 7 open-market purchases (Form 4 code P) of PTIX shares between Aug 3, 2026 and Aug 24, 2026, the most recent filed by Garo H. Armen (EXEC. CHAIR & PRINCIPAL OFF) on Aug 21, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for PTIX?
The most recent Form 4 on this page was filed by Garo H. Armen (EXEC. CHAIR & PRINCIPAL OFF) on Aug 24, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market PTIX insider purchase shown?
The largest open-market purchase among the filings shown was 20,000 PTIX shares at $0.65 (about $13,000) by Garo H. Armen (EXEC. CHAIR & PRINCIPAL OFF) on Aug 21, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent PTIX insider purchases have the Form 4 10b5-1 box checked?
No. All 7 PTIX open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Garo H. Armen (EXEC. CHAIR & PRINCIPAL OFF) on Aug 21, 2026, 20,000 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for PTIX — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.